
Not like Pfizer, Moderna can meet 2023 COVID forecast, analysts say
Syringes with needles are noticed in entrance of a displayed Moderna emblem on this representation taken, November 27, 2021. REUTERS/Dado Ruvic/Representation/Record Photograph Gain Licensing RightsNov 1(Reuters) – Moderna (MRNA.O) must hit the